| Date | Form | Description | Docs | XBRL | Pages |
| 04/15/14 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/09/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
5 | |
| 04/07/14 | UPLOAD | SEC-generated letter |
|
2 | |
| 03/31/14 | S-3/A | Registration statement for specified transactions by certain issuers |
|
101 | |
| 03/31/14 | 8-K | Current report filing |
|
4 | |
| 03/28/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 03/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/17/14 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
74 |
| 03/13/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
8 |
Latest News & Events
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Read More...